Growth • Novartis

NVS

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

1,2%

CAGR Revenue 5Y

Revenue Compound Annual Growth Rate in the last 5 years.

9,9%

CAGR Op. Income 5Y

Operating Income Compound Annual Growth Rate in the last 5 years.

0,4%

CAGR Net Income 5Y

Net Income Compound Annual Growth Rate in the last 5 years.

3%

CAGR EPS 5Y

Earnings Per Share Compound Annual Growth Rate in the last 5 years.

13,7%

CAGR Normalized EPS 5Y

Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.

5,3%

CAGR OCF 5Y

Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.

Last updated date: December 31, 2024

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!

Unrestricted access
Unlimited data history
Analysis videos
Quarterly highlights
Customizable financials table
Ranking
Discussions

...and much more!